Home/Filings/4/0001104659-21-095958
4//SEC Filing

Zhang Larry 4

Accession 0001104659-21-095958

CIK 0000895051other

Filed

Jul 25, 8:00 PM ET

Accepted

Jul 26, 6:08 PM ET

Size

5.7 KB

Accession

0001104659-21-095958

Insider Transaction Report

Form 4
Period: 2021-07-24
Zhang Larry
President, CASI China
Transactions
  • Award

    Employee Stock Option (Right to Buy)

    2021-07-24800,000800,000 total
    Exercise: $1.28Exp: 2031-07-24Common Stock (800,000 underlying)
Footnotes (2)
  • [F1]The option grant was approved by the Compensation Committee on July 24, 2021. The exercise price per share is the closing market price on July 23, 2021, the last trading day preceding the date of grant.
  • [F2]The stock options will vest as follows: 25 percent on each of the first, second, third and fourth anniversaries of the date of grant.

Issuer

CASI Pharmaceuticals, Inc.

CIK 0000895051

Entity typeother

Related Parties

1
  • filerCIK 0001754903

Filing Metadata

Form type
4
Filed
Jul 25, 8:00 PM ET
Accepted
Jul 26, 6:08 PM ET
Size
5.7 KB